Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura J Esserman

Showing results (211-220 of 308) with videos related to

Pageof 31
Sort By:
The Journal of Experimental Medicine|March 21, 2012
MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibitionDai Horiuchi, Leonard Kusdra, Noelle E Huskey, et al.
Radiology|May 25, 2012
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIALNola M Hylton, Jeffrey D Blume, Wanda K Bernreuter, et al.
Cell Reports. Medicine|January 24, 2026
Systematic annotation of orphan RNAs reveals blood-accessible molecular barcodes of cancer identity and cancer-emergent oncogenic driversJeffrey Wang, Jung Min Suh, Brian J Woo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2024
Hormone Receptor-Positive HER2-Negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple-Negative Breast CancersAlejandro Rios-Hoyo, Kaitlyn Xiong, Jiawei Dai, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Systematic annotation of orphan RNAs reveals blood-accessible molecular barcodes of cancer identity and cancer-emergent oncogenic driversJeffrey Wang, Jung Min Suh, Brian J Woo, et al.
Breast Cancer Research and Treatment|September 4, 2012
Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumorsLaura A Petrillo, Denise M Wolf, Ann M Kapoun, et al.
Breast Cancer Research and Treatment|November 30, 2014
Expression profiling of circulating tumor cells in metastatic breast cancerJulie E Lang, Janet H Scott, Denise M Wolf, et al.
NPJ Breast Cancer|August 4, 2024
Magnetic resonance imaging insights from active surveillance of women with ductal carcinoma in situHeather I Greenwood, Cristian K Maldonado Rodas, Rita I Freimanis, et al.
Annals of Surgical Oncology|May 25, 2012
Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancerRita A Mukhtar, Amy P Moore, Vickram J Tandon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2022
Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical TrialAnnelie Johansson, Huma Dar, Laura J van 't Veer, et al.
Pageof 31

Showing results (211-220 of 308) with videos related to

Sort By:
Pageof 31
The Journal of Experimental Medicine|March 21, 2012
MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibitionDai Horiuchi, Leonard Kusdra, Noelle E Huskey, et al.
Radiology|May 25, 2012
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIALNola M Hylton, Jeffrey D Blume, Wanda K Bernreuter, et al.
Cell Reports. Medicine|January 24, 2026
Systematic annotation of orphan RNAs reveals blood-accessible molecular barcodes of cancer identity and cancer-emergent oncogenic driversJeffrey Wang, Jung Min Suh, Brian J Woo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2024
Hormone Receptor-Positive HER2-Negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple-Negative Breast CancersAlejandro Rios-Hoyo, Kaitlyn Xiong, Jiawei Dai, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Systematic annotation of orphan RNAs reveals blood-accessible molecular barcodes of cancer identity and cancer-emergent oncogenic driversJeffrey Wang, Jung Min Suh, Brian J Woo, et al.
Breast Cancer Research and Treatment|September 4, 2012
Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumorsLaura A Petrillo, Denise M Wolf, Ann M Kapoun, et al.
Breast Cancer Research and Treatment|November 30, 2014
Expression profiling of circulating tumor cells in metastatic breast cancerJulie E Lang, Janet H Scott, Denise M Wolf, et al.
NPJ Breast Cancer|August 4, 2024
Magnetic resonance imaging insights from active surveillance of women with ductal carcinoma in situHeather I Greenwood, Cristian K Maldonado Rodas, Rita I Freimanis, et al.
Annals of Surgical Oncology|May 25, 2012
Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancerRita A Mukhtar, Amy P Moore, Vickram J Tandon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2022
Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical TrialAnnelie Johansson, Huma Dar, Laura J van 't Veer, et al.
Pageof 31